Table: begin end state 1 20 cytoplasmic 21 44 transmembrane 45 55 non-cytoplasmic 56 76 transmembrane 77 87 cytoplasmic 88 106 transmembrane 107 116 non-cytoplasmic 117 134 transmembrane 135 145 cytoplasmic 146 170 transmembrane 171 175 non-cytoplasmic 176 195 transmembrane 196 254 cytoplasmic 255 274 transmembrane 275 286 non-cytoplasmic 287 310 transmembrane 311 317 cytoplasmic 318 336 transmembrane 337 341 non-cytoplasmic 342 365 transmembrane 366 383 cytoplasmic 384 404 transmembrane 405 409 non-cytoplasmic 410 429 transmembrane 430 447 cytoplasmic
Input: >Pf1N1B4_2832 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_2832 MRKIDVHEVIDNARFNRFHWMVLFWCALIIIFDGYDLVIYGVVLPMLMKEWGLSPLQAGA LGSYALFGMMFGALFFGPLSDKIGRKKAITLCVMLFSGFTVLNGFARNPTEFGLCRFIAG LGIGGVMPNVVALMNEYAPKKIRSTLVAIMFSGYSVGGMLSAGLGIVLIPSFGWQSVFYV AVLPLLLLPLIMYFLPESVGFMLRQGRNQEARNVLERVDPAYVALASDQLHMSEVKGTGT PVLQLFREGRALRTLMLWLAFFCCLLMVYALSSWLPKLMANAGYSLGSSLSFLLVLNFGA IFGAVGGGVLGDKLNLPRVLAVFFVVAAVSITLLGFNSPMPVLYLLIALAGATTIGSQIL LYACAAQFYSMTIRSTGLGWASGIGRNGAIVGPLLGGALLGISLPLQLNFMAFALPGAVA ALAMTVFAISSQRSAKGATQTLAPTSA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server